» Articles » PMID: 20831431

Factors That May Influence the Experience of Hot Flushes by Healthy Middle-aged Women

Overview
Date 2010 Sep 14
PMID 20831431
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Interest in menopausal symptoms in general and hot flushes (HFs) in particular has grown in recent years. This is mostly due to increased awareness and the vast impact these symptoms have on women's lives. Despite the high prevalence of women who experience HFs, a definitive etiology for HFs is yet to be found. Our objective was to review the current literature dealing with associated factors for experiencing HFs and to provide a synthesized overview on this common and often debilitating condition.

Methods: We systematically searched the English-language literature in the PubMed database using relevant key words and included only those articles that contained information on associated factors for HFs in generally healthy midlife women.

Results: Both conflicting scientific results between studies documenting factors that influence HFs and the lack of validated measuring tools make it difficult to truly pinpoint associated factors for HFs. Nonetheless, we identified the following clusters of associated factors: the menopausal stages, sex steroid hormones, other endocrine agents, genetic polymorphisms, race/ethnicity, body mass index (BMI) and obesity, mood disorders, smoking, soy isoflavones and phytoestrogens, alcohol consumption, and physical activity.

Conclusions: No single associated factor was consistently identified as having a major role in experiencing HFs. More resources should be directed to develop a unified study system along with multivariable analyses to get a better understanding of this condition, which often imposes a tremendous social and personal toll on the women who experience it.

Citing Articles

Randomized, single-blind, placebo-controlled trial on extract pharmacopuncture for hot flashes in peri- and post-menopausal women.

Choi S, Kim D, Yoon S, Choi C, Yoo J Integr Med Res. 2022; 11(4):100891.

PMID: 36338608 PMC: 9634366. DOI: 10.1016/j.imr.2022.100891.


Urinary phthalate metabolite concentrations and hot flash outcomes: Longitudinal associations in the Midlife Women's Health Study.

Babadi R, Williams P, Li Z, Smith R, Strakovsky R, Hauser R Environ Res. 2022; 216(Pt 2):114576.

PMID: 36252832 PMC: 10445275. DOI: 10.1016/j.envres.2022.114576.


Hot Flashes in Adolescence and Young Adult Females: a Link to Vitamin D and Calcium.

Sindiani A, Alkhatatbeh M, Abdul-Razzak K Med Arch. 2022; 76(3):202-208.

PMID: 36200110 PMC: 9478824. DOI: 10.5455/medarh.2022.76.202-208.


Parabens and Menopause-Related Health Outcomes in Midlife Women: A Pilot Study.

Pacyga D, Chiang C, Li Z, Strakovsky R, Ziv-Gal A J Womens Health (Larchmt). 2022; 31(11):1645-1654.

PMID: 35787012 PMC: 10024061. DOI: 10.1089/jwh.2022.0004.


Multimodal Care for Headaches, Lumbopelvic Pain, and Dysmenorrhea in a Woman With Endometriosis: A Case Report.

Martin B J Chiropr Med. 2022; 20(3):148-157.

PMID: 35463839 PMC: 9023129. DOI: 10.1016/j.jcm.2021.10.002.


References
1.
Hahn P, Wong J, Reid R . Menopausal-like hot flashes reported in women of reproductive age. Fertil Steril. 1998; 70(5):913-8. DOI: 10.1016/s0015-0282(98)00281-7. View

2.
Gold E, Block G, Crawford S, Lachance L, FitzGerald G, Miracle H . Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol. 2004; 159(12):1189-99. DOI: 10.1093/aje/kwh168. View

3.
Cohen L, Soares C, Vitonis A, Otto M, Harlow B . Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006; 63(4):385-90. DOI: 10.1001/archpsyc.63.4.385. View

4.
Hammar M, Berg G, Lindgren R . Does physical exercise influence the frequency of postmenopausal hot flushes?. Acta Obstet Gynecol Scand. 1990; 69(5):409-12. DOI: 10.3109/00016349009013303. View

5.
Greendale G, Gold E . Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?. Am J Med. 2006; 118 Suppl 12B:148-54. DOI: 10.1016/j.amjmed.2005.09.049. View